The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Uber Technologies, Inc. (UBER), ...

A combination of homegrown capabilities and significant acquisitions has made Cognizant a key player in bringing AI to ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Ravi Singisetti; Chief Executive Officer, Director; Cognizant Technology Solutions Corp Jatin Dalal; Chief Financial Officer; Cognizant Technology Solutions Corp Thank you, operator, and good ...

Ladies and gentlemen, welcome to the Cognizant Technology Solutions’ Fourth Quarter 2024 Earnings Conference Call. All lines ...

Ladies and gentlemen, welcome to the Cognizant Technology Solutions' Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the ...

Fourth quarter revenue of $5.1 billion increased 6.8% year-over-year or 6.7% in constant currency1, at the high end of our guidance rangeFull-year revenue of $19.7 billion increased 2.0% ...

Thursday announced that it has expanded its long-standing collaboration with Gilead Sciences (GILD) to enhance cost ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to ...

Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...